Progyny, Inc.
PGNY
$27.12
-$0.03-0.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 350.51M | 328.50M | 318.40M | 313.35M | 332.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 350.51M | 328.50M | 318.40M | 313.35M | 332.87M |
| Cost of Revenue | 261.21M | 245.43M | 241.52M | 240.51M | 253.90M |
| Gross Profit | 89.30M | 83.07M | 76.88M | 72.84M | 78.97M |
| SG&A Expenses | 49.30M | 47.69M | 53.96M | 51.31M | 54.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 310.51M | 293.13M | 295.48M | 291.82M | 308.52M |
| Operating Income | 40.00M | 35.38M | 22.92M | 21.53M | 24.36M |
| Income Before Tax | 41.14M | 36.88M | 17.85M | 23.96M | 27.08M |
| Income Tax Expenses | 13.09M | 12.65M | 5.37M | 10.10M | 9.97M |
| Earnings from Continuing Operations | 28.05M | 24.23M | 12.49M | 13.86M | 17.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.05M | 24.23M | 12.49M | 13.86M | 17.11M |
| EBIT | 40.00M | 35.38M | 22.92M | 21.53M | 24.36M |
| EBITDA | 41.63M | 36.86M | 24.29M | 22.80M | 25.56M |
| EPS Basic | 0.36 | 0.30 | 0.15 | 0.16 | 0.20 |
| Normalized Basic EPS | 0.33 | 0.28 | 0.19 | 0.17 | 0.20 |
| EPS Diluted | 0.34 | 0.29 | 0.14 | 0.15 | 0.19 |
| Normalized Diluted EPS | 0.31 | 0.27 | 0.18 | 0.17 | 0.19 |
| Average Basic Shares Outstanding | 78.17M | 80.92M | 85.23M | 86.02M | 85.77M |
| Average Diluted Shares Outstanding | 82.14M | 84.76M | 89.46M | 90.23M | 89.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |